Healthcare >> CEO Interviews >> September 22, 2020
Interview with the CEO: Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN)
Robert Cobuzzi is the new CEO at Diffusion Pharmaceuticals Inc. He was a company director since January 2020. He is currently adviser to the Mitochondrial Disease Frontier Program at the Children’s Hospital of Philadelphia and Chairman of Sunstone Life Science Venture’s Business Development Board. From 2005 until 2018, he worked in senior roles at Endo International Plc, most recently as President, Endo Ventures Limited in Dublin, Ireland. Dr. Cobuzzi was a member of the U.S. Department of Commerce’s Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health/Science Products and Services, and was a board member for two development-stage medical device companies. He received an A.B. degree in biochemistry and art history from Colby College as well as a Ph.D. in molecular and cellular biochemistry from Loyola University Chicago. Profile
Word count: 3,168
TWST: You just started as CEO of the company. What's your vision for the company as you take over?